Showing results (41-50 of 72) with videos related to
Sort By:
Pageof 8
Acta Neuropathologica Communications|October 30, 2024
NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomesMichael Chang, Mohamed Sherief, Maria Ioannou, et al.NPJ Precision Oncology|July 9, 2025
RAS pathway targeted therapy in patients with DICER1-associated sarcomasLindy Zhang, Paige H R Mallinger, Serena Zhou, et al.Nature Communications|September 9, 2024
MerlinS13 phosphorylation regulates meningioma Wnt signaling and magnetic resonance imaging featuresCharlotte D Eaton, Lauro Avalos, S John Liu, et al.Scientific Data|July 15, 2025
Integrated genomic analysis of NF1-associated peripheral nerve sheath tumors: an updated biorepository datasetJineta Banerjee, Yang Lyu, Stavriani C Makri, et al.Neurosurgery|June 23, 2026
Comparative Analysis of the Prognostic Value of Simpson Grade Versus MRI-Based Extent of Resection Paradigms Across Meningioma Histomolecular SubgroupsNadeem N Al-Adli, Felix Ehret, Minh P Nguyen, et al.Neurosurgery|July 15, 2024
Genomic Alterations in Molecularly Defined OligodendrogliomasCarly Weber-Levine, Maureen Rakovec, Kelly Jiang, et al.Nature Genetics|May 17, 2024
Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolutionCalixto-Hope G Lucas, Kanish Mirchia, Kyounghee Seo, et al.Journal of Neuro-Oncology|October 9, 2024
Impact of upfront adjuvant chemoradiation on survival in patients with molecularly defined oligodendroglioma: the benefits of PCV over TMZJordina Rincon-Torroella, Maureen Rakovec, Anita L Kalluri, et al.Neurosurgery|August 30, 2020
A Prognostic Gene-Expression Signature and Risk Score for Meningioma Recurrence After ResectionWilliam C Chen, Harish N Vasudevan, Abrar Choudhury, et al.Journal of Neurosurgery|January 21, 2022
Resection with intraoperative cesium-131 brachytherapy as salvage therapy for recurrent brain tumorsWilliam C Chen, Matthieu Lafreniere, Christina Phuong, et al.Pageof 8